127 related articles for article (PubMed ID: 19788408)
21. Pretreatment for acute exposure to diisopropylfluorophosphate: in vivo efficacy of various acetylcholinesterase inhibitors.
Lorke DE; Hasan MY; Nurulain SM; Shafiullah M; Kuča K; Petroianu GA
J Appl Toxicol; 2011 Aug; 31(6):515-23. PubMed ID: 20981864
[TBL] [Abstract][Full Text] [Related]
22. Analysis of inhibition, reactivation and aging kinetics of highly toxic organophosphorus compounds with human and pig acetylcholinesterase.
Aurbek N; Thiermann H; Szinicz L; Eyer P; Worek F
Toxicology; 2006 Jul; 224(1-2):91-9. PubMed ID: 16720069
[TBL] [Abstract][Full Text] [Related]
23. Species differences in brain acetylcholinesterase response to monocrotophos in vitro.
Qadri YH; Swamy AN; Rao JV
Ecotoxicol Environ Saf; 1994 Jun; 28(1):91-8. PubMed ID: 7523071
[TBL] [Abstract][Full Text] [Related]
24. The effect of a single oral dose of tri-o-cresyl phosphate on neurotoxic esterase and acetylcholinesterase activities in the central nervous system, erythrocytes and plasma.
Barrett DS; Oehme FW
Vet Hum Toxicol; 1994 Feb; 36(1):1-4. PubMed ID: 8154093
[TBL] [Abstract][Full Text] [Related]
25. Acetylcholinesterase inhibitor pretreatment alters stress-induced expression of acetylcholinesterase transcripts in the mouse brain.
Dori A; Oriel S; Livneh U; Duek O; Lin T; Kofman O
Neuroscience; 2011 Jun; 183():90-8. PubMed ID: 21453753
[TBL] [Abstract][Full Text] [Related]
26. Gene transfer of acetylcholinesterase protects the knockout mouse from the toxicity of DFP.
Li B; Duysen EG; Lockridge O
J Mol Neurosci; 2006; 30(1-2):79-80. PubMed ID: 17192637
[TBL] [Abstract][Full Text] [Related]
27. Aging of mipafox-inhibited human acetylcholinesterase proceeds by displacement of both isopropylamine groups to yield a phosphate adduct.
Kropp TJ; Richardson RJ
Chem Res Toxicol; 2006 Feb; 19(2):334-9. PubMed ID: 16485911
[TBL] [Abstract][Full Text] [Related]
28. Comparative studies of O,O-dialkyl-O-chloromethylchloroformimino phosphates: interaction with neuropathy target esterase and acetylcholinesterase.
Makhaeva GF; Filonenko IV; Yankovskaya VL; Fomicheva SB; Malygin VV
Neurotoxicology; 1998; 19(4-5):623-8. PubMed ID: 9745921
[TBL] [Abstract][Full Text] [Related]
29. Tacrine protection of acetylcholinesterase from inactivation by diisopropylfluorophosphate: a circular dichroism study.
Wu CS; Yang JT
Mol Pharmacol; 1989 Jan; 35(1):85-92. PubMed ID: 2913485
[TBL] [Abstract][Full Text] [Related]
30. Kinetic evidence for different mechanisms of acetylcholinesterase inhibition by (1R)- and (1S)-stereoisomers of isomalathion.
Jianmongkol S; Marable BR; Berkman CE; Talley TT; Thompson CM; Richardson RJ
Toxicol Appl Pharmacol; 1999 Feb; 155(1):43-53. PubMed ID: 10036217
[TBL] [Abstract][Full Text] [Related]
31. Use of in vitro data in developing a physiologically based pharmacokinetic model: Carbaryl as a case study.
Yoon M; Kedderis GL; Yan GZ; Clewell HJ
Toxicology; 2015 Jun; 332():52-66. PubMed ID: 24863738
[TBL] [Abstract][Full Text] [Related]
32. Interaction of pentylsarin analogues with human acetylcholinesterase: a kinetic study.
Worek F; Herkert NM; Koller M; Aurbek N; Thiermann H
Toxicol Lett; 2009 Jun; 187(2):119-23. PubMed ID: 19429253
[TBL] [Abstract][Full Text] [Related]
33. Depression of acetylcholinesterase synthesis following transient cerebral ischemia in rat: pharmacohistochemical and biochemical investigation.
Malatová Z; Gottlieb M; Marsala J
Gen Physiol Biophys; 1999 Mar; 18(1):57-71. PubMed ID: 10378121
[TBL] [Abstract][Full Text] [Related]
34. Comparison of the in vitro sensitivity of rat acetylcholinesterase to chlorpyrifos-oxon: what do tissue IC50 values represent?
Mortensen SR; Brimijoin S; Hooper MJ; Padilla S
Toxicol Appl Pharmacol; 1998 Jan; 148(1):46-9. PubMed ID: 9465262
[TBL] [Abstract][Full Text] [Related]
35. Postnatal diisopropylfluorophosphate enhances conditioned vigilance in adult BALB/c and C57BL/6 mice and alters expression of acetylcholinesterase splice variants.
Oriel S; Dori A; Kofman O
Behav Pharmacol; 2014 Oct; 25(7):661-72. PubMed ID: 25171079
[TBL] [Abstract][Full Text] [Related]
36. In vitro and in vivo action of diisopropylfluorophosphate, of atropine and their synergism on acetylcholinesterase activity.
Molinengo L; Ghi P
Pharmacology; 1989; 39(3):154-9. PubMed ID: 2587621
[TBL] [Abstract][Full Text] [Related]
37. Different role of carboxylesterases in toxicity and tolerance to paraoxon and DFP.
Dettbarn WD; Yang ZP; Milatovic D
Chem Biol Interact; 1999 May; 119-120():445-54. PubMed ID: 10421482
[TBL] [Abstract][Full Text] [Related]
38. A physiologically based pharmacokinetic model for the oxime TMB-4: simulation of rodent and human data.
Sterner TR; Ruark CD; Covington TR; Yu KO; Gearhart JM
Arch Toxicol; 2013 Apr; 87(4):661-80. PubMed ID: 23314320
[TBL] [Abstract][Full Text] [Related]
39. Physiologically based pharmacokinetic/pharmacodynamic model for the organophosphorus pesticide diazinon.
Poet TS; Kousba AA; Dennison SL; Timchalk C
Neurotoxicology; 2004 Dec; 25(6):1013-30. PubMed ID: 15474619
[TBL] [Abstract][Full Text] [Related]
40. Antioxidant and acetylcholinesterase response to repeated malathion exposure in rat cerebral cortex and hippocampus.
Trevisan R; Uliano-Silva M; Pandolfo P; Franco JL; Brocardo PS; Santos AR; Farina M; Rodrigues AL; Takahashi RN; Dafre AL
Basic Clin Pharmacol Toxicol; 2008 Apr; 102(4):365-9. PubMed ID: 18341513
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
